Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer

ATEŞ, ÖZTÜRK; BABACAN, TANER; KERTMEN, NEYRAN; Sarici, Furkan; Cenoli, Alma; AKIN, SERKAN; Karakas, Yusuf; KILIÇKAP, SAADETTİN; Ozisik, Yavuz; SEVER, ALİ; AKSOY, SERCAN; Altundag, Kadri

Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer

Copy For Citation

ATEŞ Ö., BABACAN T., KERTMEN N., Sarici F., Cenoli A., AKIN S., ...More

JOURNAL OF BUON, vol.21, no.2, pp.375-381, 2016 (SCI-Expanded)

Publication Type: Article / Article
Volume: 21 Issue: 2
Publication Date: 2016
Journal Name: JOURNAL OF BUON
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.375-381
Hacettepe University Affiliated: Yes

Abstract

Purpose: Eribulin is a non-taxane microtubule inhibitor, which can be used after anthracycline and taxane treatment in patients with metastatic breast cancer (MBC). The purpose of this study was to investigate the efficacy and safety of eribulin monotherapy in heavily pretreated MBC patients.